Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kumiko Takezawa
Local Administration of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor May Provide a New Therapeutic Potential for the Treatment of Intractable Upper Airway Inflammation
Journal of Japan Society of Immunology & Allergology in Otolaryngology
Related publications
Quantitative Tyrosine Phosphoproteomics of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-Treated Lung Adenocarcinoma Cells Reveals Potential Novel Biomarkers of Therapeutic Response
Molecular and Cellular Proteomics
Biochemistry
Medicine
Analytical Chemistry
Molecular Biology
Specific, Irreversible Inactivation of the Epidermal Growth Factor Receptor and erbB2, by a New Class of Tyrosine Kinase Inhibitor
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Therapeutic Potential of Epidermal Growth Factor Receptor-Related Protein
Molecular Cancer Therapeutics
Cancer Research
Oncology
Inhibition of Chronic and Acute Skin Inflammation by Treatment With a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor
American Journal of Pathology
Forensic Medicine
Pathology
Nucleotide Binding by the Epidermal Growth Factor Receptor Protein-Tyrosine Kinase
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Bone Metastases: Different Mechanisms of Action for a Novel Therapeutic Application?
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
Strategies for Molecular Imaging of Epidermal Growth Factor Receptor Tyrosine Kinase in Cancer
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Lung Cancer Cells Survive Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Exposure Through Upregulation of Cholesterol Synthesis
FASEB BioAdvances
Early Radiographic Response to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor in Non-Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations: A Prospective Study
Biomedical Journal
Medicine
